Nostrum Laboratories Calcium Acetate Capsules Recall: Foreign Tablets Present
Nostrum Laboratories recalls 667mg Calcium Acetate Capsules (Rx Only) due to foreign tablets. This prescription medication may contain unsafe materials.
Lower-risk recall
Presence of Foreign Tablets/Capsules
Contact the company
What happened, in plain English
Nostrum Laboratories is recalling prescription Calcium Acetate Capsules (667 mg, 200 capsules per bottle) because they may contain foreign tablets. This could pose a safety risk if the capsules are taken as intended. Read more at govinfonow.com/recall/40816-nostrum-laboratories-calcium-acetate-capsules-recall-foreign-tablets-present.
Source Summary by GovInfoNow · govinfonow.com/recall/40816-nostrum-laboratories-calcium-acetate-capsules-recall-foreign-tablets-present · Updated October 7, 2026 · FDA enforcement record: FDA #D-0473-2018
Cite this page
“Nostrum Laboratories Calcium Acetate Capsules Recall: Foreign Tablets Present.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/40816-nostrum-laboratories-calcium-acetate-capsules-recall-foreign-tablets-present. Based on FDA recall #D-0473-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0473-2018%22&limit=1).
Why it’s dangerous
The capsules may contain foreign tablets that could cause harm if ingested. This is a prescription medication used for specific medical conditions, so patients must follow their doctor's instructions.
Who’s affected
Prescription patients who have purchased these Calcium Acetate Capsules from pharmacies or online. Those with medical conditions requiring this medication are most at risk.
How to tell if you have this one
Check for the product name 'Calcium Acetate Capsules', 667 mg, 200 capsules per bottle, and the NDC code 29033-026-02. The lot number is CAL173502 and expiration date is 09/19.
- Brand
Nostrum Laboratories- Category
Drug
What to do — step by step
Check Product Details
Look for the NDC code 29033-026-02, lot number CAL173502, and expiration date 09/19 on the packaging.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 10 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Is this product safe to use?
The recall states the capsules may contain foreign tablets, so they should not be used until the manufacturer confirms the issue is resolved.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0473-2018 (February 13, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0473-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.